JR

Jyotirmoy Roy Karmakar

Director Director DIN 08657687
DIN 08657687 First appointment Jan 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2020
Shareholding value •••• Premium profile

About Jyotirmoy Roy Karmakar

Data last updated:

Jyotirmoy Roy Karmakar was a Director at Feminova Pharmaceuticals Private Limited (2021–2024) and Whole-Time Director at Novo Medix Pharmaceutical Private Limited (2020–2024). The companies operate in Pharma.

DIN 08657687
Primary Designation Director
Industry Pharma
First Appointment 03 Jan 2020

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Apr 20212021Active
Whole-Time Director03 Jan 20202020₹2.52 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Feminova Pharmaceuticals Private Limited
Novo Medix Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Jyotirmoy Roy Karmakar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyotirmoy Roy Karmakar

Jyotirmoy Roy Karmakar was first appointed on 03 Jan 2020 as Whole-Time Director at Novo Medix Pharmaceutical Private Limited. The most recent appointment on record is 01 Apr 2021 at Feminova Pharmaceuticals Private Limited.

Jyotirmoy Roy Karmakar held 2 earlier board appointments: Feminova Pharmaceuticals Private Limited (Director, 01 Apr 2021 to 02 Aug 2024); Novo Medix Pharmaceutical Private Limited (Whole-Time Director, 03 Jan 2020 to 02 Aug 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available